Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-155535
Dated February 11, 2010

JPMorgan ETN report

The table below summarizes certain data related to the Alerian MLP Index ETNs
(the "Notes" or the "ETNs")
- --------------------------------------------------------------------------------
                                                          Indicative   Closing
                                                Closing     Value     Indicative
  Product Name      CUSIP    Ticker   Date     Price ($)    Ticker     Value ($)
- --------------------------------------------------------------------------------
JPMorgan Alerian
 MLP Index ETN    46625H365   AMJ    2/11/2010   $28.50     AMJIV       $28.53
- --------------------------------------------------------------------------------

- ----------------------------------------------------------------------------
                  Market       Total                      Last
  Number of   Capitalization   Assets    Last Coupon   Coupon Ex-
 Notes (000s)      ($ M)        ($M)     per Note ($)      Date       Fee
- ----------------------------------------------------------------------------
                                                                      0.85%
   25,000         $712.50     $713.25      0.4431      11/25/2009     p.a.
- ----------------------------------------------------------------------------

The ETNs are senior, unsecured debt obligations of JPMorgan Chase & Co. and
accordingly, are exposed to the credit risk of JPMorgan Chase & Co.

Definitions
"Closing Price" means the last trade reported as of the date shown.
"Closing Indicative Value" means the last level calculated for the intraday
indicative value of the ETN for the relevant day. The intraday indicative value
(the "IIV") is meant to approximate the intrinsic economic value of the ETN.
The IIV calculation is provided for reference purposes only. It is not intended
as a price or quotation. The IIV will be based on the intraday indicative
values of the Alerian MLP Index, and may not be equal to the payment at
maturity or upon early repurchase. Please see the relevant pricing supplement
for details.
"Number of Notes" means the total number of notes, shown in thousands, that
have been issued, including those held by JPMorgan Chase & Co or one of its
affiliates.
"Market Capitalization" means the product of the Number of Notes and the
Closing Price, shown in millions. This includes any ETNs held by JPMorgan Chase
& Co or any of its affiliates.
"Total Assets" means the product of the Number of Notes and the Closing
Indicative Value.
"Last Coupon per Note" means the most recent Coupon Amount paid by the issuer
of the Note to investors. Please see the relevant Pricing Supplement for the
definition of Coupon Amount.
"Last Coupon Ex-Date" means the "ex-date" with respect to the most recent
Coupon Amount, as more fully described in the relevant Pricing Supplement.
"Fee" refers to the to the Tracking Fee as defined in the relevant Pricing
Supplement.

You should read the most recent pricing supplement related to these ETNs dated
December 9, 2009 before you make an investment. You may access this pricing
supplement on the SEC website at www.sec.gov as follows:
http://www.sec.gov/Archives/edgar/data/19617/000089109209004638/e37276_424b2.htm

SEC Legend: JPMorgan Chase & Co. has filed a registration statement (including
a prospectus) with the SEC for any offerings to which these materials relate.
Before you invest, you should read the prospectus in that registration
statement and the other documents relating to this offering that JPMorgan Chase
& Co. has filed with the SEC for more complete information about JPMorgan Chase
& Co. and this offering. You may get these documents without cost by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, JPMorgan Chase & Co.,
any agent or any dealer participating in this offering will arrange to send you
the prospectus and each prospectus supplement as well as any product
supplement, pricing supplement and term sheet if you so request by calling
toll-free 800-576-3529.

Free Writing Prospectus Related to Registration Statement No. 333-155535
To the extent there are any inconsistencies between this free writing
prospectus and the relevant pricing supplement, the relevant pricing
supplement, including any hyperlinked information, shall supersede this free
writing prospectus.

Investment suitability must be determined individually for each investor. The
financial instruments described herein may not be suitable for all investors.
This information is not intended to provide and should not be relied upon as
providing accounting, legal, regulatory or tax advice. Investors should consult
their own advisors on these matters.
IRS Circular 230 Disclosure: JPMorgan Chase & Co. and its affiliates do not
provide tax advice. Accordingly, any discussion of U.S. tax matters contained
herein (including any attachments) is not intended or written to be used, and
cannot be used, in connection with the promotion, marketing or recommendation
by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters address
herein or for the purpose of avoiding U.S. tax-related penalties. The tax
consequences of the ETNs are uncertain.

"Alerian MLP Index and Alerian MLP Total Return Index are trademarks of an
affiliate of Alerian Capital Management, LLC and their use is granted under a
license with such affiliate."

                                                              February 11, 2010